Le Lézard
Classified in: Science and technology, Business
Subjects: JVN, ACC, VEN

Mantis Vision Raises $55 Million in Series D Funding, Announces Joint Venture With Luenmei Quantum Co. Ltd.


PETACH TIKVA, Israel, July 16, 2018 /PRNewswire/ -- Mantis Vision, a leading provider of advanced 3D sensing, volumetric content acquisition and sharing technologies, today announced the closing of its Series D round of $55 million with a total investment of $83 million to date. New funds will serve to extend the company's technological edge, accelerate Mantis Vision's go-to-market strategy, expand its international workforce and support external growth opportunities. The Series D investment was led by Luenmei Quantum Co. Ltd., a new investor in Mantis Vision, and Samsung Catalyst Fund, an existing shareholder of the company. Mantis Vision and Luenmei Quantum Co. also announced the formation of a new joint venture, "MantisVision Technologies", to further strengthen Mantis Vision's position and growth in the Greater China Market.

Founded and headquartered in Israel, Mantis Vision offers advanced 3D content capture and sharing technologies for a wide array of applications ? from 3D cameras for smartphones, industrial/professional grade 3D camera/scanners, and up to a live 3D Volumetric studio. Under this new round of funding, Mantis Vision will be able to extend its R&D efforts by advancing today's state of conventional 3D technology to new heights with its 3D sensing technology.  

The creation of "MantisVision Technologies" will strengthen Mantis Vision's position in the Greater Chinese market. With operating offices in Beijing and Shanghai, the JV will further support the introduction of Mantis Vision's products and technology and provide localization, local sales and support functions in the region.

Mantis Vision is planning to double its global workforce with an additional 140 employees in Israel, U.S., China and Slovak Republic by the end of 2020. As part of the latest series funding, Mantis Vision will expand its pool of talent engineers for advanced R&D algorithmic research in computer vision and deep learning, advanced optics experts, mobile camera engineers, 3D apps developers and 3D Volumetric studio experts amongst other open positions in program management and business development. Opportunities for global scale are already underway with Mantis Vision and smartphone maker Xiaomi's latest partnership to implement Mantis Vision's 3D camera technology in recently announced Xiaomi's new premium flagship smartphone, the Mi8.

According to Mr. So Chong Keung, Luenmei Quantum Co. Ltd. President and GM: "Luenmei Quantum is closely following the Israeli high-tech industry, which creates outstanding technology. Mantis Vision's versatile and advanced 3D technologies is well positioned and suited for mobile, secure face ID applications and entertainment industries in China. We found that Mantis Vision is the right match for Luenmei Quantum, combining hi-tech, innovation and passion."

According to David Goldschmidt, VP and Managing Director of Samsung Catalyst Fund: "We humans sense the world in rich 3D. However, current camera technology is 2D, limiting the ways we communicate and create content. It also limits capabilities of machines to do more for us. Mantis Vision is leading the way toward 3D sensor tech that is small in form factor and low-cost enough to be widely deployed in devices of all kinds. In the future, high-resolution 3D imaging will make for everything from smarter vacuums and safer vehicles, and everyday consumers will become 3D content creators. The possibilities are practically limitless."

According to Gur Arie Bitan, Founder and CEO of Mantis Vision: "This latest announcement is another proof of Mantis Vision's meteoric advancements in this recent period, technologically and business-wise. We regard our continued partnership with Samsung Catalyst Fund and Luenmei Quantum Co. as a strategic partnership and thanks to our new joint venture, we will be able to further strengthen our grip in the Greater Chinese market."

About Mantis Vision:

Mantis Vision brings high definition 3D content to everyday experiences. Mantis Vision empowers consumers, application developers and industry professionals to instantly capture and share high-quality 3D Volumetric content. From 3D cameras on mobile devices to professional 3D scanners to a live 3D Volumetric studio our technology easily transforms objects, places and live people into high-resolution 3D digital content, in real-time.

MantisVision Technologies is Mantis Vision's exclusive partner for the Greater China market. MantisVision Technologies is headquartered in Shanghai with offices in Beijing and Shenzhen.

Press Contact:
Aviram Sisso: Mantis Vision PR Account Manager
[email protected]
Mobile: +972-52-8223221
www.Item-media.co.il

Mantis Vision Contact:
Tal Fridkin: Marketing Manager
[email protected]
Tel: +972-73-248-0108
Mobile: +972-52-347-4386

www.mantis-vision.com

 

 

SOURCE Mantis Vision


These press releases may also interest you

at 07:15
Pipedrive, the easy and effective sales CRM for small businesses, is launching Pipedrive AI, a broad range of AI tools powered by OpenAI and internally developed AI software engines. The new product suite aims to take the manual work out of sales,...

at 07:15
As GROWMARK, Inc. continues to position itself to lead in the digital agronomy space, it has partnered with Intelinair, an ag data analytics company, on a new digital agronomy application to equip its farmer customers with data-driven insights to...

at 07:15
Arch Biopartners Inc., ("Arch" or the "Company") , announced today that a research team from St. Michael's Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac...

at 07:11
Fiat infrastructure leader Banxa will add Venom-supported tokens to its Fiat onramp infrastructure, used by leading crypto exchanges such as Okx, Kucoin, Gate.IO, Bybit and others. Integrating Venom foundation network to the Banxa Fiat rails will...

at 07:10
IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") today announced that interim data from its Phase 2 clinical trial demonstrates a clinically significant reduction, approaching statistical significance, in agitation in Alzheimer's at week two...

at 07:10
Curida Holding AS ("Curida") has announced a significant growth investment from Signet Healthcare Partners ("Signet"), a New York-based healthcare private equity firm. This strategic partnership will enable Curida to accelerate its expansion plans,...



News published on and distributed by: